This page is part of the Genetic Reporting Implementation Guide (v3.0.0-ballot: STU 3 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions
: GenomicReportExample01 - JSON Representation
Raw json | Download
{
"resourceType" : "DiagnosticReport",
"id" : "GenomicReportExample01",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/genomic-report"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h2><span title=\"Codes: {http://loinc.org 51969-4}, {http://loinc.org 57979-7}\">HLA-B*15:02 [Presence]</span> (<span title=\"Codes: {http://terminology.hl7.org/CodeSystem/v2-0074 GE}\">Genetics</span>) </h2><table class=\"grid\"><tr><td>Subject</td><td><b>Adam B. Everyman </b> male, DoB: 1951-01-20 ( Medical Record Number:\u00a0m123\u00a0(use:\u00a0USUAL))</td></tr><tr><td>When For</td><td>2016</td></tr><tr><td>Reported</td><td>2018-03-06 00:00:00-0500</td></tr></table><p><b>Report Details</b></p><table class=\"grid\"><tr><td><b>Code</b></td><td><b>Value</b></td><td><b>When For</b></td></tr><tr><td><a href=\"Observation-TherapeuticImplicationExample1.html\"><span title=\"Codes: {http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs therapeutic-implication}\">Therapeutic Implication</span></a></td><td/><td>2019-04-01</td></tr><tr><td><a href=\"Observation-GenotypeExample1.html\"><span title=\"Codes: {http://loinc.org 84413-4}\">Genotype display name</span></a></td><td><span title=\"Codes: {http://www.ncbi.nlm.nih.gov/clinvar 14909}\">HLA-B*15:02</span></td><td>2019-04-01</td></tr><tr><td><a href=\"Observation-OverallInterpExample1.html\"><span title=\"Codes: {http://loinc.org 51968-6}\">Discrete variation analysis overall interpretation</span></a></td><td><span title=\"Codes: {http://loinc.org LA6576-8}\">Positive</span></td><td>2019-04-01</td></tr></table></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/recommended-action",
"valueReference" : {
🔗 "reference" : "Task/MedicationRecommendationExample1"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/workflow-relatedArtifact",
"valueRelatedArtifact" : {
"type" : "citation",
"url" : "https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19)"
}
}
],
"basedOn" : [
{
🔗 "reference" : "ServiceRequest/GenomicServiceRequestExample01"
}
],
"status" : "final",
"category" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
"code" : "GE"
}
]
}
],
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "51969-4"
},
{
"system" : "http://loinc.org",
"code" : "57979-7",
"display" : "HLA-B*15:02 [Presence]"
}
]
},
"subject" : {
🔗 "reference" : "Patient/CGPatientExample01"
},
"effectiveDateTime" : "2016",
"issued" : "2018-03-06T00:00:00-05:00",
"performer" : [
{
🔗 "reference" : "Organization/ExampleOrg"
}
],
"result" : [
{
🔗 "reference" : "Observation/TherapeuticImplicationExample1",
"display" : "impact for high risk allele"
},
{
🔗 "reference" : "Observation/GenotypeExample1"
},
{
🔗 "reference" : "Observation/OverallInterpExample1"
}
]
}